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Cholesterol Dictates the Freedom of EGF Receptors and HER2 in the
Plane of the Membrane
Galya Orr, Dehong Hu, Serdar O¨zcxelik, Lee K. Opresko, H. Steven Wiley, and Steven D. Colson
Chemical and Biological Sciences Divisions, Pacific Northwest National Laboratory, Richland, Washington 99354
ABSTRACT The flow of information through the epidermal growth factor receptor (EGFR) is shaped by molecular interactions
in the plasma membrane. The EGFR is associated with lipid rafts, but their role in modulating receptor mobility and subsequent
interactions is unclear. To investigate the role of nanoscale rafts in EGFR dynamics, we used single-molecule fluorescence
imaging to track individual receptors and their dimerization partner, human epidermal growth factor receptor 2 (HER2), in the
membrane of human mammary epithelial cells. We found that the motion of both receptors was interrupted by dwellings within
nanodomains. EGFR was significantly less mobile than HER2. This difference was likely due to F-actin because its depo-
lymerization led to similar diffusion patterns between the EGFR and HER2. Manipulations of membrane cholesterol content
dramatically altered the diffusion pattern of both receptors. Cholesterol depletion led to almost complete confinement of the
receptors, whereas cholesterol enrichment extended the boundaries of the restricted areas. Interestingly, F-actin depo-
lymerization partially restored receptor mobility in cholesterol-depleted membranes. Our observations suggest that membrane
cholesterol provides a dynamic environment that facilitates the free motion of EGFR and HER2, possibly by modulating the
dynamic state of F-actin. The association of the receptors with lipid rafts could therefore promote their rapid interactions only
upon ligand stimulation.
INTRODUCTION
The epidermal growth factor receptor (EGFR) conveys ex-
tracellular information to the intracellular compartment. The
information transfer is initiated by ligand binding that
induces dimerization of the receptor with itself or with other
members of the erbB family. Receptor dimerization and
other molecular interactions in the plane of the membrane are
likely affected by the membrane microenvironment. Both
EGFR and its dimerization partner, human EGFR 2 (HER2
or erbB2), have been found associated with lipid rafts (1,2),
which are membrane microdomains that are enriched in
cholesterol and sphingolipids. It is thought that small and
transient ‘‘reserved’’ rafts coalesce into larger and relatively
stable rafts upon cell stimulation or receptor oligomerization
(3) and serve as intermediate structures in the signaling
process (4–6). The involvement of lipid rafts in EGFR
signaling has been investigated by manipulating the content
of membrane cholesterol, which alters both raft structures
and signaling pathways (7–11). However, the mechanism by
which lipid rafts affect EGFR signaling is unclear.
Lipid rafts, defined by their isolation as a low-density
fraction from cold detergent membrane extracts, are dis-
persed by depletion of membrane cholesterol. Cholesterol
depletion, therefore, might indicate the involvement of lipid
rafts with certain cellular functions but cannot exclude the
involvement of other structures, such as the actin cytoskel-
eton, in these processes (12,13). For example, phosphatidyl-
inositol (4,5)-bisphosphate (PIP2), which is a major regulator
of the actin cytoskeleton, has been shown to be delocalized
from the membrane with cholesterol depletion (14,15). The
sequestration of PIP2, like cholesterol depletion, alters the
organization of actin and inhibits the lateral diffusion of
membrane proteins (16). The motion of membrane proteins
is confined by the cortical, membrane-associated F-actin
(17–19). The actin strands in the cytoskeleton network are
thought to stericly interact with the cytoplasmic tail of the
proteins, confining them into microdomains. Single particle
tracking (SPT) techniques have supported this view (12,20–
24). These studies have suggested that corrals are formed by
immobilized membrane-associated proteins that interact with
the cytoskeleton, together creating fences and pickets within
the plasma membrane (25–28). Membrane proteins were
found to dwell, on the order of seconds, within transient con-
finement zones that could represent lipid rafts (29–35). The
EGFR itself has also been shown to be associated with
F-actin (36–38) and this interaction is thought to play an
important role in receptor signaling (39–42). Interestingly,
the EGFR has been shown to evoke cortical actin poly-
merization and stress fiber breakdown (43–45). The effect of
EGFR on F-actin has been linked to PIP2 (46,47), which also
accumulates in lipid rafts (48).
To better understand the functional significance of the
association of the EGFR and its dimerization partner with
lipid rafts, we used time-dependent single-molecule fluores-
cence imaging to identify and quantify the motion patterns
of the receptor and its dimerization partner, HER2. In-
dividual EGFR and HER molecules were followed in human
mammary epithelial (HME) cells while manipulating the
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cholesterol content of the membrane and the dynamic state of
F-actin. Our observations suggest that membrane cholesterol
plays a potent modulatory role in the lateral mobility of both
EGFR and HER2 in the membrane and thereby provides a
possible mechanism by which cholesterol modulation affects
receptor activation.
MATERIALS AND METHODS
Fluorescence microscopy
A fluorescence laser microscope (Axiovert 200, Zeiss, Jena, Germany)
equipped with a 1003 oil-immersion objective (Plan-Apochromat, nu-
merical aperture ¼ 1.4, Zeiss) and a 23 relay lens in the emission path to the
charge-coupled device (CCD) camera was used for wide-field single-
molecule imaging. The overall magnification was 2003, leading to 100 nm
per image pixel. A green laser (Nd:YAG Verdi V-10, Coherent, Santa Clara,
CA) was used to excite the dye (Alexa Fluor (AF)-546, Molecular Probes,
Eugene, OR) at 532 nm wavelength. The laser was coupled by a fiber
coupler to the microscope, and the illumination intensity was adjusted to
5 kW/cm2. An ultrafast shutter, controlled by the CCD controller, was set in
front of the laser beam to produce 10 ms laser exposures at 7.5 Hz. The
dichroic beam-splitter and band-pass emission filters (Chroma Technology,
Brattleboro, VT) were set to collect the emission between 550 nm and
600 nm. Single-molecule fluorescence images were acquired by a back-
illuminated cooled CCD camera (Spec-10 1340 3 400B, Roper Scientific,
Trenton, NJ) with 90% quantum efficiency and single-molecule sensitivity.
It is estimated that one intensity count in the CCD image corresponds to two
detected photons.
Calculating the position and intensity of
individual receptors
The center of individual fluorescent spots was determined by the Gaussian
mask algorithm (49) by iterations of the following equation:
x ¼ + iSijGij
+ SijGij
;
where Sij is the photon counts at pixel (i, j), Gij is a two-dimensional (2D)
Gaussian function with a peak x and a full width at half maximum (FWHM)
that equals 300 nm, which is given by the point-spread function of the
microscope. Because Gij depends on x, the calculation of x is iterated until x
is converged. The accuracy of the Gaussian mask algorithm was tested both
experimentally and by mathematical simulations. Experimentally, individual
dye molecules were fixed on a polymer surface and were used as a model
system to determine the uncertainty in the position of the fluorescent spot.
Simulations were done using single-molecule images of 600 photons per
spot, with 30 background photons per pixel, which is at the lower end of the
value found in our experiment. Both simulations and experimental results
suggest that the accuracy of the fitting is within 20 nm.
Single-molecule fluorescence intensities were calculated by the summa-
tion of a 3 3 3 pixels area, which is at the diffraction limit size. For a 2D
Gaussian intensity profile with 300 nm at FWHM, 60% of the intensity falls
within the 33 3 pixels (100 nm/pixel). The intensities of single fluorophores
were determined by spin coating glass coverslips with picomolar concen-
trations of the dye. The individual fluorescent hotspots were regarded as
single molecules if their size met the diffraction limit and they photobleached
in single steps. Intensity histograms, generated from hundreds of hotspots,
indicated the expected fluorescence counts of single fluorophores under our
experimental parameters. Intensity histograms of antibodies labeled with the
fluorophores were generated as described above and were compared with the
histograms generated from the fluorophores alone.
Calculating mean square displacement, diffusion
coefficient, and mm scale domains
The mean square displacement (MSD) values of individual receptors are
defined by the following equation: MSD ¼ Ær(t)2æ where r is the distance
between steps in time t. When the change in MSD was nonlinear with
time and the curve could be fitted by the equation for confined diffusion
(20,32), a restricted motion was assumed where MSD reached maximum
at infinity: MSDt/N ¼ Ær2ðNÞæ. Closer to time 0 where the change in
MSD was linear, single-molecule diffusion was considered as Brownian
motion and the diffusion coefficient, D, was calculated according to:
MSDt/0 ¼ 4Dt.
The confinement area was calculated following Kusumi and colleagues
(32). Assuming a square shape, the confinement area was calculated
according to 3Ær2ðNÞæ.
Distinguishing nanoscale confinement episodes
from random behavior
To distinguish random behavior from true confinement episodes, the method
described by Simson and colleagues (29) was applied. A circle was created
around any given point in a trajectory to include an increasing number of
following points. The radius of all these circles was used to calculate the
probability of staying within the circles by random motion, using the diffu-
sion coefficient we found and the uncertainty in our tracking (0.25 pixel).
The smallest probability was then tested against a threshold to identify the
confinement episodes that are beyond random motion, within every point in
the trajectory. If a point was determined to be within a confinement area, the
radius was taken for calculating the average confinement size. The threshold
value that we found depicted molecules that were confined within a circle
with a radius (R) ¼ 50 nm. When simulated trajectories of a random walk
were tested, hardly any episodes of dwellings within R¼ 50 nm were found.
FRAP measurements
Fluorescence recovery after photobleaching (FRAP) was done by photo-
bleaching a circular area (2.5 mm at FWHM) with 10 ms laser exposures.
Using the intensity values that were found before and immediately after
photobleaching, K, which describes the fractional depth of photobleaching
(50), was calculated. Using K and the value of the recovery time at half
maximum derived from our data, the characteristic t (tc) was calculated and
found to be 80 s for EGFR and 50 s for HER2. The diffusion coefficients
were then calculated according to D ¼ w2/4tc.
Cell culture and transfection
The HME 184A1 cell line was a kind gift from Martha Stampfer (Lawerence
Berkeley National Laboratory, Berkeley, CA). The cell line was used to
create the HER2 overexpressing cell line by retroviral transduction, as is
described elsewhere (51). Briefly, a retroviral vector containing HER2 was
constructed and transfected into the CCRIP packaging cell line. The
transfectant clones were screened for HER2 expression using mAb 4D5
against HER2, and the supernatants were screened for high virus titers.
Individual clones of retrovirus transfected cells were isolated using cloning
rings, and the degree of HER2 expression was determined by immunoflu-
orescence, flow cytometry, and equilibrium-binding studies using labeled
Fab fragments. The average number of HER2 molecules per cell was 3 3
105. The cells were grown in DFCI-1 medium supplemented with 12.5 ng/ml
EGF, and HER2 overexpressing cells were grown in the same medium with
the addition of 100 mg/ml G418-sulfate. All cells were grown in 30 mm
tissue culture plates with a glass coverslip bottom.
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Fab fragments, generation, and labeling
mAb 13A9 against EGFR and the Fab fragment of mAb 7C2 against HER2
were gifts from Genentech (San Francisco, CA). It has been shown that both
13A9 and 7C2 antibodies do not activate the receptors (52,53). Fab
fragments of mAb 13A9 were generated using agarose bead-immobilized
papain (Pierce, Rockford, IL). The immunoglobulins were dialyzed against
20 mM Na2HPO4/10 mM EDTA for 24 h, followed by incubation with
immobilized papain in digestion buffer (20 mM cysteine-HCl, 10 mM
EDTA, pH 7.0) for 48 h in 37C. The Fab fragments were then separated
from undigested whole IgG and Fc by a protein A column. The fraction
containing Fab fragments was dialyzed against phosphate buffer saline
(PBS; pH 7.4), and its purity was confirmed by SDS gel electrophoresis. The
Fab fragments (50 KD) were labeled with AF-546 using succinimidyl ester
derivatives of the dyes in PBS at pH 8.0. The coupling reaction was carried
out at room temperature for 60 min with continual stirring. Labeled Fab
fragments were separated from the fluorophore using G-25 gel filtration.
The degree of labeling (DOL) was calculated according to Lambert-Beer
Law and ranged within 0.7–1.5 for all labeled Fab fragments used in this
study. These values were verified by spin coating nM concentrations of the
labeled Fab fragments on glass coverslips followed by the generation of
intensity histograms of individual diffraction-limited hotspots, as described
above.
For tagging receptors with labeled Fab fragments, cells were grown to
70% confluence and were brought to quiescence by overnight incubation in
minimal growth medium (without EGF, bovine pituitary extract, or fetal
bovine serum) containing 0.1% bovine serum albumin (BSA). Cells were
incubated for 1 h with 1% BSA before labeling. Receptor labeling was
carried out by 10 min incubation at room temperature with AF-546-tagged
Fab fragments at 20–30 nM concentration. Cells were washed and imaged
in physiological buffer containing NaCl (162 mM), KCl (2.5 mM), CaCl2
(1.0 mM), glucose (10 mM), HEPES (10 mM), pH 7.4.
Drug application
All reagents were purchased from Sigma (St. Louis, MO) unless noted
otherwise. To deplete membrane cholesterol, cells were preincubated in the
minimal growth medium with no HEPES, serum, or BSA. Cells were then
incubated with 10 mM Methyl-b-cyclodextrin (MbCD) in the same medium
for 30 min at 37C. Staining with labeled antibodies was followed using the
protocol described above, except no BSA was added to the incubation
medium. To enrich the membrane with cholesterol, cells were preincubated
in the growth medium containing 1% BSA and 300 mg/ml water-soluble
cholesterol, balanced with MbCD (54,55). This gives a 1:6.25 mol ratio of
cholesterol to MbCD at a final concentration of 5 mM MbCD and 0.8 mM
cholesterol. The incubation was carried out at 37C for 3 h. Cells were then
incubated with the antibody as described above. To depolymerize F-actin,
cells were incubated for 3 h in their normal growth medium with 5 mM
latrunculin A (Biomol, Plymouth Meeting, PA). Cytochalasin D, which
leads to depolymerization of F-actin by capping the (1) end of the filament,
was also used. Cells were incubated for 30 min in their normal growth
medium with 5 mM cytochalasin D. Cells were then washed and incubated
for 10 min with the growth medium containing 1% BSA and were labeled
with the antibody as described above.
RESULTS
Single-molecule fluorescence microscopy was used to track
individual nonactivated EGF receptors and HER2 molecules
in the membrane of HME cells to determine the rate and
pattern of the lateral motion of the receptors. Individual re-
ceptors, tagged by fluorescent Fab fragments of the corre-
sponding antibodies, were tracked as they appeared in a small
membrane area that was photobleached (3 mm2, correspond-
ing to the FWHM of the laser profile).
Identifying single molecules
Single molecules were identified by the following criteria:
(A), The size of the fluorescent spot was the size of the
diffraction limit, about half of the excitation wavelength with
the 1.4 numerical aperture objective we used. A spot con-
taining one AF-546 dye molecule is expected to be;270 nm
(with 532 nm laser excitation), slightly ,3 3 3 pixels (see
Fig. 2 A). (B), The fluorescent spot blinked and photo-
bleached in one discrete step. Fig. 1 shows a typical example
of antibody-tagged receptors at the membrane adjacent to the
culture dish, demonstrating blinking and single-step photo-
bleaching (see also movie-1 and movie-2 in the supplemen-
tary material). (C), The intensity of the fluorescent spot fell
within the intensity range of single fluorophores, spin coated
on glass slides at picomolar concentrations. The expected
fluorescence intensity of a single AF-546 molecule under our
specific experimental conditions was 251 6 109 counts per
3 3 3 pixels during 10 ms laser exposure, as determined by
imaging hundreds of individual dye molecules (Fig. 2, B and
C, solid bars). The distribution of individual fluorescent
spots in the cell membrane was slightly shifted to a higher
intensity (Fig. 2, B and C, open bars). The peak distributions
of hotspots containing antibodies against EGFR and HER2
were 298 6 78 and 306 6 100, respectively. The slight
increase in the peak distributions could result from the pre-
sence of antibodies labeled with more than one dye molecule
as the DOL ranged from 0.7 to 1.5. The shift could also
potentially result from the presence of a small pool of pre-
formed dimers. However, the spots that met all three criteria
described above were treated as individual receptors and
were pursued for further analysis.
Relative mobility of EGFR and HER2 in the plane
of the membrane
Individual EGFR and HER2 molecules were tracked at the
lower and upper membrane of the cells (movie-2 in the
supplementary material). Although the size of the fluorescent
spot is limited by the resolution of the microscope, the center
of the spot can be determined by fitting a 2D Gaussian curve
to the spot (56). Fitting 2D Gaussian curves using iterations
of least-squares estimators allowed us to determine the
motion of the spot to an ;20 nm resolution (49). Examples
of traces, taken by tracking individual EGFR and HER2
molecules in the lower membrane of the cells, are shown in
Fig. 3, A and B, respectively, encased within 1 mm2 squares.
The images were taken every 130 ms, which was the time
resolution of our experiments. With this time resolution, it
was possible to capture short periods, on the order of 1 s,
where the trajectories interrupted by receptor dwellings
within nanoscale domains (red circles) before diffusing
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away. To quantify the diffusion pattern and rate of the two
receptors, we first calculated the MSD of individual
molecules. Fig. 4 A shows the changes in MSD over time,
as determined from traces of 180 EGF receptors (open
circles) and 120 HER2 molecules (solid circles). The
nonlinear change of MSD with time suggests that the motion
of the receptors was restricted, and the curves were fitted by
the equation for confined diffusion (20,32) (solid line). From
the plateau of the fitted curves, and assuming a square shape,
we estimated that EGFR and HER2 diffused within micro-
domains of 1.23 6 0.06 mm and 1.65 6 0.16 mm,
respectively. The diffusion coefficient (D) that was calcu-
lated from the linear part of the curve (closer to time 0)
showed 0.023 6 0.002 mm2/s for EGFR and 0.035 6 0.004
mm2/s for HER2. The significantly smaller diffusion co-
efficient of EGFR relative to HER2 could result from the
direct interaction of EGFR with F-actin (36,39,40). To test
this possibility, the cells were treated with drugs that
depolymerize F-actin. Cytochalasin D, which is a fungal
alkaloid that caps the (1) end of F-actin, was used. The drug
blocks further addition of subunits and leads to F-actin
depolymerization over time. By incubating the cells with
cytochalasin D, we found that the diffusion coefficient of
EGFR but not HER2 was increased (0.027 6 0.003 mm2/s).
Both EGFR and HER2 restricted domains were increased
(1.5 6 0.19 mm and 1.95 6 0.29 mm, respectively) as well
(Fig. 4 B). Using a highly potent drug, latrunculin A, which
is secreted by sponges and inhibits the addition of G-actin to
the filament end, yielded more profound results. From the
traces of the receptors in latrunculin-treated cells, it was
found that the diffusion coefficient of EGFR (0.032 6 0.003
mm2/s, n ¼ 180) and the size of its restricting microdomains
(1.68 6 0.1 mm) became similar to those of HER2 under
control conditions (Fig. 4 C, open circles). The diffusion
coefficient of HER2 was not changed by latrunculin treat-
ment (0.0296 0.003 mm2/s; n ¼ 70; Fig. 4 C, solid circles).
However, the boundaries of HER2 restricted domains dis-
appeared, as indicated by the linear change of MSD with
time. It is possible that the boundaries of the restricted
domains were extended by the toxin, but the molecules
photobleached before these boundaries were reached. The
difference in the degree of domain extensions between
EGFR and HER2 could be explained if the depolymerization
of F-actin was incomplete, leading to a greater restriction of
EGFR motion via its direct interaction with intact filaments.
Identification of short nanoscale confinement
episodes of both HER2 and the EGFR
Within the time resolution of our experiment (130 ms), it was
not possible to capture the ‘‘hop’’ diffusion between nano-
domains that dominated the behavior of other membrane
FIGURE 1 A series of consecutive images, taken at
130 ms intervals, showing individual AF-546-Fab
fragment-tagged receptors as they entered a small
photobleached area in the membrane of HME cells.
Individual molecules were detected by their fluores-
cence blinking as shown in the third image (upper
fluorescent spot within the circle) and by their single-
step photobleaching as shown in the seventh image
(upper spot) and the ninth image (lower spot). Also see
movie-1 and movie-2 in the supplementary material.
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proteins reported earlier (24,57–60). However, it was
possible to capture episodes, on the order of 1 s, where the
trajectories interrupted by receptor dwellings within nano-
scale domains (Fig. 3, red circles). To identify whether these
episodes were guided by specific cellular structures or
interactions, it was necessary to rule out the possibility that
they could occur by a random behavior. We followed the
approach for determining the probability threshold above
FIGURE 2 Expected fluorescence intensity of individual molecules was
determined from the histogram that was generated by imaging the
fluorophore alone, spin coated on glass slides at picomolar concentrations.
(A) An example of raw images of diffraction-limited fluorescent spots of
,300 nm2 (3 3 3 pixels) that were pursued for further analysis. The spots
were fitted by a 2D Gaussian distribution with 300 nm at FWHM. The peak
of the distribution was considered the center of the molecule, which was
determined with 20 nm resolution. (B) The histogram, generated from 600
fluorescent spots of AF-546 dye molecules spin coated on glass slides at pM
concentrations (solid bars), peaked at 252 6 78 counts per 3 3 3 pixels
during a 10 ms laser exposure. This value indicates the expected intensity of
individual receptors under our specific experimental conditions. The
distribution that was generated from the intensities of spots containing
AF-546-tagged EGFR that appeared in the photobleached membrane areas
(open bars) peaked at 298 6 78 counts per 300 nm2 (n ¼ 600). (C) The
fluorescence intensity distribution, generated from the fluorescent spots of
AF-647-tagged HER2 molecules in the cell membrane (open bars), peaked
at 306 6 100 (n ¼ 600). Because the degree of Fab fragment-labeling was
distributed around 1, it is expected that some Fab fragments were labeled
with more than one dye molecule, which could explain the shift in the
intensity distribution of the spots in the cell membrane. This shift could also
reflect the appearance of dimers in the photobleached area.
FIGURE 3 Traces of individual molecules show that the receptors diffuse
freely within larger microscale domains, interrupted by short confinement
episodes within nanoscale domains. (A) Typical traces of individual EGFR
receptors showing their diffusion pattern in the plane of the membrane under
normal conditions. The traces were taken in the lower membrane of the cell
and are shown within 1 mm2 (103 10 pixels) frames. Short dwellings within
nanodomains are indicated by the circles. (B) The same pattern is observed
by tracking individual HER2 molecules.
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which such confinement episodes would not occur by random
walk (29), as described under Materials and Methods. The
average radius (R) of all trajectory points that fell above
the threshold was 50 nm, for both EGFR and HER2. Using
the diffusion coefficient that we found for each receptor type
under normal conditions and the experimental tracking
uncertainty (25 nm), simulation of random walk showed
almost no cases of three consecutive trajectory points within
R ¼ 50 nm. However, episodes of three or more consecutive
trajectory points within R ¼ 50 nm were identified in EGFR
and HER2 traces. The sum of all the points in the con-
finement episodes showed that EGFR spent 10% 6 2% of
the time within these nanodomains, for an average time of
1.4 6 0.2 s (total of 180 traces) under control conditions
(Fig. 5, control). Similarly, HER2 spent 9% 6 3% of the
time inside the nanodomains, for an average time of 1.3 6
0.2 s (total of 120 traces). Interestingly, F-actin depolymer-
ization by latrunculin A or cytochalasin D did not change
significantly the fraction of time that EGFR and HER2 spent
within the 50 nm radius domains (Fig. 5).
Modulation of both EGFR and HER2 diffusion
by altering membrane cholesterol and
F-actin polymerization
To identify the role of membrane cholesterol in governing the
pattern of EGFR and HER2 motion in the plane of the
membrane, Fab-tagged receptors were tracked in the mem-
brane of cells that were enriched or depleted of cholesterol. A
dramatic change was observed with both manipulations. Fig.
6 A shows traces of individual EGFR within 1.2 mm2 squares
taken from cholesterol-enriched membranes. On average, the
traces covered a larger area of the membrane than traces
obtained from control cells (Fig. 3 A). In contrast, cholesterol
depletion led to an almost complete confinement of the
receptors to nanoscale domains, with short and rare escapes.
Examples of traces taken from cholesterol-depleted mem-
branes are shown in Fig. 6 B framed by 0.5 mm2 squares.
Similar patterns were observed for HER2. Calculations of
MSD changes over time revealed that although cholesterol
FIGURE 4 Change in MSD over time, as calculated from traces of
individual receptors, identified microdomain confinements within which
HER2 diffused faster than EGFR. (A) The nonlinear change of MSD over
time, as calculated from 180 traces of individual EGFR (s) and 120 traces of
individual HER2 molecules, suggests that the receptors were confined
within microscale domains. By fitting the curves with the equation for
confined diffusion (solid line) and assuming a square shape, the confinement
area was found to be 1.23 6 0.06 mm for EGFR and 1.65 6 0.16 mm for
HER2. The diffusion coefficient of the receptors was calculated from the
linear part of the curve (closer to time 0), showing that HER2 was more
mobile (0.035 6 0.004 mm2/s) than EGFR (0.023 6 0.002 mm2/s). (B)
Treating the cells with cytochalasin D to depolymerize F-actin increased the
diffusion coefficient of EGFR (0.0276 0.003 mm2/s, n¼ 40,s) but did not
change the diffusion coefficient of HER2 (0.0356 0.004 mm2/s, n¼ 40,d).
The toxin also extended the boundaries of the restricted domains of both
receptors (EGFR: 1.5 6 0.19 mm; HER2: 1.95 6 0.29 mm). (C) Using
a more potent drug to depolymerize F-actin, latrunculin A, led to the increase
in the diffusion coefficient of EGFR (0.032 6 0.003 mm2/s, n ¼ 180, s) to
the same level as that of HER2. The diffusion coefficient of HER2 was not
changed by the toxin (0.0296 0.003 mm2/s, n¼ 70,d). As indicated by the
linear change of MSD with time, the toxin extended the boundaries of HER2
restricted domains beyond the ability of the experiment to detect them,
which was limited by the photobleaching time of the individual molecules.
Latrunculin A extended the boundaries of EGFR restricted domains to the
same level as that of HER2 under normal conditions (1.656 0.1 mm). These
observations suggest that the direct interaction of EGFR with F-actin slows
down the motion of the receptor in the plane of the membrane.
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enrichment did not change the diffusion coefficient of HER2
(0.0296 0.003mm2/s) (Fig. 7A, solid circles), it increased the
diffusion coefficient of EGFR (0.030 6 0.003 mm2/s) to the
same level as that of HER2 (Fig. 7 A, open circles) and
extended the boundaries of the domains of both receptors. We
inferred that the boundaries were extended from the linear
change of MSD over the duration of the experiment but could
not measure them directly because of the relatively rapid
photobleaching times of the individual fluorophores. In-
terestingly, the time that the two receptors spent within the
nanodomains did not change significantly from control
conditions by cholesterol enrichment (Fig. 5, cholesterol
enrichment) as determined by the identification of the
nanoscale confinement episodes based on their probabilistic
deviation from random walk. In contrast, the time that EGFR
and HER2 spent within the nanoscale domains increased
dramatically in cholesterol-depleted membranes from;10%
to 77% 6 12% and 91% 6 15%, respectively (Fig. 5,
cholesterol depletion). The diffusion coefficient of both
receptors was smaller than the resolution of our experiment
(0.002 mm2/s; Fig. 7 B) in cholesterol-depleted cells.
However, when cholesterol-depleted cells were treated with
latrunculin A, the diffusion coefficient of EGFR was partially
restored (0.017 6 0.002 mm2/s; Fig. 7 B, asterisks). These
observations suggest that the confinement of the receptors by
cholesterol depletion might occur via modulation of the
dynamic state of F-actin, possibly via membrane dislocation
of (4,5) PIP2 (12–15). Sequestering of PIP2, like cholesterol
depletion, has been reported to alter cell actin organization
and inhibit the lateral diffusion of membrane proteins (16).
Comparison of single-molecule measurements
to whole receptor populations
Ensemble FRAP measurements cannot identify diffusion
patterns such as restricted diffusion and nanoscale short
FIGURE 6 Manipulations of the cholesterol content of the membrane
changed the pattern of the lateral motion of the receptors. (A) Examples of
EGFR traces in cholesterol-enriched membranes encased within 1.2 mm2
boxes. The receptors covered, on average, larger areas than those covered
under normal conditions. (B) Traces of the receptors in cholesterol-depleted
membranes, shown within 0.5 mm2 boxes, were highly confined to nano-
scale domains, with short and rare escapes.
FIGURE 5 Episodes of dwellings within nanodomains, on the order of
1 s, were identified by their probabilistic deviation from random walk,
suggesting the involvement of specific cellular structures. The average
radius of all trajectory points that fell above the threshold for nonrandom
behavior was 50 nm for both receptors. Whereas simulations of random walk
showed almost no episodes of three consecutive points within 50 nm radius
domains, both EGFR and HER2 showed a significant number of such
confinement episodes. EGFR spent 10% 6 2% of its time for an average
time of 1.46 0.2 s, and HER2 spent 9%6 3% of its time for an average time
of 1.3 6 0.2 s within the nanodomains under normal conditions. Similar
values were observed in latrunculin A or cytochalacin D treated cells and in
membrane enriched with cholesterol. However, a dramatic increase in the
fraction of time that the receptors spent within the nanodomains was
observed in cholesterol-depleted membranes. EGFR spent 77%6 12%, and
HER2 spent 91% 6 15% of their time inside the 50 nm radius domains, for
an average time of 2.2 s and 2.9 s, respectively.
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confinement episodes or identify subtle differences in
diffusion coefficients. However, FRAP measurements were
used here to verify that the diffusion coefficients, found by
single-molecule measurements, reflect the diffusion coef-
ficient of the whole population rather than a selected sub-
population. An example of the fluorescence images that were
used for calculating FRAP are shown in Fig. 8 A. The first
image was followed by photobleaching with 10 s exposure to
the laser beam, indicated by the circle at FWHM. Images
were taken every 30 s for the next 8 min, where the
fluorescence recovery leveled off (third image). From the
fluorescence recovery over time and following the approach
of Axelrod and colleagues (50) described in the Materials
and Methods section, the diffusion coefficients of EGFR and
HER2 were found to be 0.014 6 0.007 mm2/s and 0.022 6
0.01 mm2/s, respectively (Fig. 8 B). These values are slightly
lower than those we found using single-molecule tracking. In
the case of single-molecule tracking, the diffusion coef-
ficients are calculated from the initial part of the MSD curve,
reflecting the free diffusion. However, in the case of FRAP,
the calculations include both the free and the confined dif-
fusion and therefore are expected to be lower. The values we
found by FRAP show the same tendency for a higher dif-
fusion coefficient for HER2 relative to EGFR and suggest
that the single-molecule approach describes the mobility
pattern of the population at large rather than a subpopulation.
DISCUSSION
The principal new finding to emerge from this work is the
role of membrane cholesterol in providing a dynamic envi-
ronment that supports the lateral movement of EGFR and
HER2 in the plane of the membrane. We propose a possible
mechanism whereby the modulation of receptor mobility
FIGURE 7 Change of MSD with time, calculated from traces that were
taken in cholesterol-enriched or -depleted membranes, shows that cho-
lesterol provides a dynamic environment that supports the free motion of the
receptors. (A) Cholesterol enrichment did not change the diffusion
coefficient of HER2 (0.029 6 0.003 mm2/s, n ¼ 50; filled circles) but
increased the diffusion coefficient of EGFR to the same level as that of
HER2 (0.036 0.003 mm2/s, n ¼ 80,s). Cholesterol enrichment caused the
boundaries of the restricted domains to extend beyond the tracking time
window as determined by the linear change of MSD with time for both
receptors. (B) Cholesterol depletion led to a dramatic decrease in the
diffusion coefficient of EGFR and HER2 (s and d, respectively) below
0.002 6 0.0002 mm2/s, which is the resolution limit of our experiments.
However, treating cholesterol-depleted cells with latrunculin A led to a
partial recovery of the diffusion coefficient (0.0176 0.002mm2/s, n¼ 30, *)
of the receptors, suggesting that the modulation of receptor mobility by mem-
brane cholesterol occurs via modulation of F-actin.
FIGURE 8 Single-molecule measurements represent the whole popula-
tion as determined by ensemble FRAP measurements. (A) An example of
images that were used for calculating FRAP, where the diameter of the laser
beam is indicated by the circle at FWHM (2.5 mm). (B) Normalized
fluorescence intensities were plotted against time (images taken every 30 s),
and the diffusion coefficient of the receptors was calculated as described in
the text. The diffusion coefficient calculated by FRAP for EGFR (0.014 6
0.007 mm2/s, n ¼ 10 cells, h) and HER2 (0.022 6 0.01 mm2/s, n ¼ 10
cells, n) show the same tendency of a higher diffusion coefficient for
HER2 relative to EGFR, as was found by single-molecule tracking.
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could arise from F-actin polymerization underneath choles-
terol-enriched lipid rafts. We quantified the confined motion
pattern of the two receptors and identified, by deviations
from random walk, dwellings within 50 nm domains that
could indicate specific cellular interactions. This work also
demonstrates that HER2 is more mobile in the plane of the
membrane than EGFR, a difference that could result from the
ability of EGFR to directly interact with F-actin (36–38).
This idea is supported by our observation that F-actin
depolymerization increased the diffusion coefficient of
EGFR, raising it to the same level as that of HER2. The
idea is also supported by several studies showing that
deletion mutations of the intracellular domains significantly
affected the diffusion rate and pattern of certain membrane
proteins. These experiments were done using FRAP (22) or
single-particle tracking and optical tweezers (23,24). Using
FRAP, it was also reported that cytoplasmic deletion muta-
tions did not affect the diffusion coefficient of EGFR, which
was tagged by fluorescent ligands (60). The use of fluo-
rescent ligands might have partially masked the effects of the
mutations by stabilizing preexisting or inducing new asso-
ciations at the cell membrane. Our study was done with
endogenous EGFR receptors naturally expressed by HME
cells. Using heterologous cells that do not express endog-
enous EGFR, it will be possible to directly evaluate the
contribution of EGFR and F-actin interaction by transfecting
with either a wild-type or a mutated receptor lacking the actin
binding site (39,42).
Whereas the diffusion coefficient of EGFR has been
reported earlier using FRAP (60–64) or SPT (32), the
diffusion coefficient of HER2 has not previously been
measured. The reported values for EGFR ranged around 0.02
mm2/s, which agrees with the value we found here by
following individual receptors (0.023 6 0.002 mm2/s). The
diffusion coefficient of HER2 (0.035 6 0.003 mm2/s) was
significantly higher than that of EGFR, a difference that
disappeared with F-actin depolymerization (Fig. 4, B and C)
or cholesterol enrichment (Fig. 7 A). Both F-actin depoly-
merization and cholesterol enrichment extended the bound-
aries of the restricted areas but did not change the degree of
receptor dwellings within the nanodomains that we could
capture intermittently along the trajectories (Fig. 5). These
observations suggest a common mechanism for both treat-
ments, both acting on the dynamic state of F-actin either
directly or indirectly. However, this mechanism must be
different from the mechanism underlying the infrequent
episodes of nanodomain dwellings, on the order of 1 s, that
we observed within the larger microdomains.
The time resolution of our experiment (130 ms) could
not allow the capturing of the ‘‘hop’’ diffusion between
milliseconds dwellings in nanoscale domains, which are
thought to be formed by F-actin (24,57–59). The longer-
lived nanodomains that we observed were not affected by
F-actin manipulations and therefore could not reflect a sub-
population of the short-lived nanodomains mentioned above.
The nanodomains that we observed could represent the
transient confinement zones reported earlier (29–31,35).
However, these zones were suggested to represent lipid rafts
and therefore are expected to be affected by cholesterol
manipulations. Our results are not entirely consistent with
this idea because the time of confinement within nano-
domains was affected only by cholesterol depletion but not
by enrichment. We therefore believe that different mecha-
nisms underlie the nanodomain dwellings that we observed
under normal conditions (or cholesterol enrichment) and
those under cholesterol depletion. It is conceivable that the
dwellings in nanodomains that we observed intermittently
within the microdomains under normal conditions are caused
by episodes of spontaneous dimerization (65–67) or molec-
ular interactions with scaffolding and downstream molecules
and possibly the consequent formation of more ‘‘stable’’ rafts
(68). In contrast, the dramatic increase in nanodomain
dwellings that was caused by cholesterol depletion could be
explained by the relationship of lipid-rafts with F-actin as
described below.
The restriction of the lateral mobility of transmembrane
proteins by cholesterol depletion has been observed before
(16,69,70) but not in all cases (71,72). Using laser trapping
of HLA molecules labeled with antibody-coated beads,
Kwik and colleagues (16) found that with cholesterol
depletion, the molecules became significantly more confined
by elastic elements of the cytoskeleton as determined by the
snapping of the molecules back to the point of origin once
they encountered an obstacle and escaped from the trap.
Using optical laser tweezers, Suzuki and colleagues (73,74)
identified two types of cytoskeleton-dependent barriers:
elastic barriers involving weak but specific bonds to the actin
cytoskeleton and small nonelastic barriers that depended on
membrane cholesterol. Together, these observations suggest
that cholesterol depletion might lead to receptor confine-
ment by acting on F-actin (12,13). The intimate relationships
between lipid rafts and the actin cytoskeleton have been
observed before (75–77).
Cholesterol depletion has been shown to result in the
reorganization and stabilization of membrane-associated
actin (14), and this reorganization could occur, at least in
part, as a result of the membrane dislocation of PIP2 that is
a consequence of cholesterol depletion (16). PIP2 enhances
F-actin polymerization by stimulating the activity of WASP
family proteins that activate the nucleation and filament
branching of actin, among other mechanisms (15). PIP2
accumulates in rafts by binding to myristoylated alanine-rich
PKC-substrate and related proteins (78). It has been
suggested that rafts could serve as platforms for the
integration of PIP2 action and actin polymerization, creating
specialized membrane microdomains that are associated with
specific cytoskeletal structures (15). Dislocating PIP2 from
the membrane could create a submembrane area that is less
dynamic by suppressing F-actin polymerization, increasing
the constraints on receptor mobility. In support of this view,
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we observed the partial recovery of receptor motion by
treating cholesterol-depleted cells with latrunculin A (Fig. 7
B), where F-actin depolymerization led to an increase in the
diffusion coefficient and a decrease in the confinement that
cholesterol depletion caused. Cholesterol enrichment, on the
other hand, could create submembrane areas that are more
dynamic by enhancing F-actin polymerization. In support of
this interpretation is our observation that latrunculin A
treatment and cholesterol enrichment had similar effects
on the diffusion coefficient of the receptors and the same
tendency to increase the size of the restricted areas.
Together, our observations could be explained by a model
in which cholesterol-rich membrane areas, or lipid rafts,
provide active structures for the polymerization of F-actin,
possibly by the recruitment of PIP2, that in turn create a
dynamic environment in the submembrane area that allows
transmembrane proteins to freely diffuse within the choles-
terol-rich areas. Cholesterol enrichment increases the size of
the rafts and enhances their ability to form a reticular network
at the cell surface. In so doing, cholesterol enrichment
creates larger platforms for the active polymerization of
F-actin, leading to the significant increase that we observed
in the size of the microdomains. This increase can also be
achieved by direct manipulation of F-actin, as we observed.
Cholesterol depletion disperses or decreases the size of the
rafts and dissociates their networks. By doing that, choles-
terol depletion arrests F-actin polymerization, possibly via
PIP2 dislocation, leading to the observed dramatic increase in
the confinement of the receptors within nanodomains. Direct
depolymerization of F-actin should counteract the effect of
cholesterol depletion, as we observed. It is possible that
under normal conditions, the network and the individual rafts
determine the size of the microdomains and the nanodomains
(observed with high time resolution by others), respectively.
Interestingly, F-actin polymerization has been reported to
localize to the activated EGFR (43,45), which could be ex-
plained by EGFR activation of PLCg, leading to PIP2 hydro-
lysis and an increase in F-actin turnover (46), all in association
with lipid rafts where these molecules accumulate.
Cholesterol depletion has been shown to increase the
binding of EGF to the EGFR (1,7,8) and to increase receptor
dimerization, autophosphorylation, and tyrosine kinase ac-
tivity (1,8,10,11). In contrast, cholesterol enrichment has been
reported to decrease EGF binding and EGFR activation in
cells (1,7) and increase the affinity of reconstituted receptors
in vesicles (9). However, the mechanisms underlying the
effects of cholesterol manipulations on the receptor are un-
clear. Based on our observations, the effects of cholesterol
manipulations on EGFR activation and ligand binding could
be explained in the context of receptor mobility in the plane
of the membrane. It is possible that with cholesterol deple-
tion, receptors that become almost immobile and highly
confined tend to persist as activated dimers, which have a
higher affinity for EGF (79). In contrast, cholesterol en-
richment increases the mobility and freedom of the receptors
in the plane of the membrane, which could decrease their
likelihood of dimerization and activation. Because HER2
activation depends on its ability to form heterodimers with
the EGFR, the presence of both receptors in cholesterol-
enriched membrane domains might be an important aspect
that regulates their activation upon ligand stimulation.
Ligand stimulation is thought to induce formation of larger
and more stable rafts that, in turn, could preserve the spatial
information conveyed by the receptor through the mem-
brane-associated signal transduction (58). The activation of
EGFR has been shown to provide spatial and positional
information during normal development (80–82) or tumor
invasion (83). The association of EGFR and HER2 with the
lipid raft network could therefore increase the reliability of
the spatial information transduced by the receptors.
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